BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piek A, Meijers WC, Schroten NF, Gansevoort RT, de Boer RA, Silljé HH. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure. J Card Fail 2017;23:12-9. [PMID: 27224553 DOI: 10.1016/j.cardfail.2016.05.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Yan X, Feng X, Gao Y, Liu D, Bai L, Xu L. Study on the mechanism of HE4 in hyperoxia-induced alveolar damage in rats.. [DOI: 10.1101/2022.09.22.509120] [Reference Citation Analysis]
2 Luo J, Liang J, Wang S, Huang S, Zhou L, Shi Y, Zhang J, Wang Y, Wu BQ, Li L. Serum human epididymis secretory protein 4 correlates with sepsis-associated acute respiratory distress syndrome and 28-day mortality in critically ill patients. Ann Clin Biochem 2022;:45632221103805. [PMID: 35549539 DOI: 10.1177/00045632221103805] [Reference Citation Analysis]
3 Liu W, Zhang Y, Liu H, Song T, Wang S, Ahmad S. Influence of Health Education Based on IMB on Prognosis and Self-Management Behavior of Patients with Chronic Heart Failure. Computational and Mathematical Methods in Medicine 2022;2022:1-13. [DOI: 10.1155/2022/8517802] [Reference Citation Analysis]
4 Savarese G, Uijl A, Ouwerkerk W, Tromp J, Anker SD, Dickstein K, Hage C, Lam CSP, Lang CC, Metra M, Ng LL, Orsini N, Samani NJ, van Veldhuisen DJ, Cleland JGF, Voors AA, Lund LH. Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction. ESC Heart Fail 2022. [PMID: 35388650 DOI: 10.1002/ehf2.13917] [Reference Citation Analysis]
5 Cheng Z, Cai K, Xu C, Zhan Q, Xu X, Xu D, Zeng Q. Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-Analysis. Front Cardiovasc Med 2022;9:783707. [DOI: 10.3389/fcvm.2022.783707] [Reference Citation Analysis]
6 Wu Y, Cao L, Qi J. Elevated Serum HE4 Concentrations and Risk of Cardiac Complications among Hospitalized Patients with Burns. Lab Med 2022:lmab110. [PMID: 35134974 DOI: 10.1093/labmed/lmab110] [Reference Citation Analysis]
7 Mickiewicz KK, Lisowska A, Knapp M. Cardiac fibrosis and atrial fibrillation. Postępy Higieny i Medycyny Doświadczalnej 2022;76:307-314. [DOI: 10.2478/ahem-2022-0035] [Reference Citation Analysis]
8 Tang Y, Wang Y, Xu X, Tu LY, Huang P, Yang X, Li L, Wu J, Zhang Y, Fu Q, Yu Y, Zheng Z, Song L, Zhang Y. Human epididymis protein 4: a novel predictor of ischemic cardiomyopathy. BMC Cardiovasc Disord 2021;21:511. [PMID: 34674652 DOI: 10.1186/s12872-021-02319-5] [Reference Citation Analysis]
9 Guo L, Song B, Xiao J, Lin H, Chen J, Su X. The Prognostic Value of Biomarkers on Detecting Non-Small Cell Lung Cancer in a Chinese Elderly Population. Int J Gen Med 2021;14:5279-86. [PMID: 34522127 DOI: 10.2147/IJGM.S331311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Meijers WC, Bayes-Genis A, Mebazaa A, Bauersachs J, Cleland JGF, Coats AJS, Januzzi JL, Maisel AS, McDonald K, Mueller T, Richards AM, Seferovic P, Mueller C, de Boer RA. Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC). Eur J Heart Fail 2021;23:1610-32. [PMID: 34498368 DOI: 10.1002/ejhf.2346] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
11 Grams ME, Surapaneni A, Chen J, Zhou L, Yu Z, Dutta D, Welling PA, Chatterjee N, Zhang J, Arking DE, Chen TK, Rebholz CM, Yu B, Schlosser P, Rhee EP, Ballantyne CM, Boerwinkle E, Lutsey PL, Mosley T, Feldman HI, Dubin RF, Ganz P, Lee H, Zheng Z, Coresh J. Proteins Associated with Risk of Kidney Function Decline in the General Population. J Am Soc Nephrol 2021;32:2291-302. [PMID: 34465608 DOI: 10.1681/ASN.2020111607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Park H, Lee DW, Kim MJ, Shin JE, Lee HN. Low serum T3 levels are associated with false-positive results when using the risk of ovarian malignancy algorithm (ROMA) in women with benign ovarian disease. Taiwan J Obstet Gynecol 2021;60:36-40. [PMID: 33495005 DOI: 10.1016/j.tjog.2020.10.006] [Reference Citation Analysis]
13 Yamamoto M, Hanatani S, Araki S, Izumiya Y, Yamada T, Nakanishi N, Ishida T, Yamamura S, Kimura Y, Arima Y, Nakamura T, Takashio S, Yamamoto E, Sakamoto K, Kaikita K, Matsushita K, Morimoto S, Ito T, Tsujita K. HE4 Predicts Progressive Fibrosis and Cardiovascular Events in Patients With Dilated Cardiomyopathy. J Am Heart Assoc 2021;10:e021069. [PMID: 34320813 DOI: 10.1161/JAHA.120.021069] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Tan S, Zeng Y, Kuang S, Li J. Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population. Diabetes Metab Syndr Obes 2021;14:1601-8. [PMID: 33889001 DOI: 10.2147/DMSO.S300940] [Reference Citation Analysis]
15 Drake I, Hindy G, Almgren P, Engström G, Nilsson J, Melander O, Orho-Melander M. Methodological considerations for identifying multiple plasma proteins associated with all-cause mortality in a population-based prospective cohort. Sci Rep 2021;11:6734. [PMID: 33762603 DOI: 10.1038/s41598-021-85991-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Bai F, Li T, Li B, Li X, Zhu L. Serum Human Epididymis Protein 4 Level is Associated with Cognitive Function in Patients with Diabetes Mellitus. Diabetes Metab Syndr Obes 2020;13:3919-24. [PMID: 33122928 DOI: 10.2147/DMSO.S274413] [Reference Citation Analysis]
17 Lin H, Xiao J, Su X, Song B. The Association Between Serum Human Epididymis Protein 4 Level and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease. Lab Med 2021;52:260-6. [PMID: 33009814 DOI: 10.1093/labmed/lmaa076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Shi C, van der Wal HH, Silljé HHW, Dokter MM, van den Berg F, Huizinga L, Vriesema M, Post J, Anker SD, Cleland JG, Ng LL, Samani NJ, Dickstein K, Zannad F, Lang CC, van Haelst PL, Gietema JA, Metra M, Ameri P, Canepa M, van Veldhuisen DJ, Voors AA, de Boer RA. Tumour biomarkers: association with heart failure outcomes. J Intern Med 2020;288:207-18. [PMID: 32372544 DOI: 10.1111/joim.13053] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
19 Huang Y, Jiang H, Zhu L. Human Epididymis Protein 4 as an Indicator of Acute Heart Failure in Patients with Chronic Kidney Disease. Lab Med 2020;51:169-75. [PMID: 31245814 DOI: 10.1093/labmed/lmz041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
20 Jin Q, Tang Y, Liu Z, Xie W, Luo Q, Zhao Z, Zhao Q, Huang Z, Yu X, Yan L, Xiong C, Ni X, Yan Y. Serum human epididymis protein 4 level as a predictor of clinical worsening in idiopathic pulmonary arterial hypertension: a pilot study. BMC Cardiovasc Disord 2020;20:175. [PMID: 32295533 DOI: 10.1186/s12872-020-01461-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Surmiak P, Szymkowiak M, Baumert M. Human Epididymis Protein 4 Levels in Neonates with Respiratory Disorder. Biomed Res Int 2020;2020:1509379. [PMID: 32337222 DOI: 10.1155/2020/1509379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Li L, Yao Y, Liang J, Zhan X, Wang F, Yue C, Wu BQ, Hu S, Liu M, Wan J, Luo J. Serum human epididymis protein 4 concentrations are associated with severity of patients with pulmonary tuberculosis. Clin Chim Acta 2020;502:255-60. [PMID: 31730821 DOI: 10.1016/j.cca.2019.11.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Zhang M, Zhao B, Xie J, Liang Y, Yang Z. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus. Biomed Res Int 2019;2019:4831459. [PMID: 31815140 DOI: 10.1155/2019/4831459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Gasiorowska E, Kluz T, Lipski D, Warchoł W, Tykarski A, Nowak-Markwitz E. Human Epididymis Protein 4 (HE4) Reference Limits in Polish Population of Healthy Women, Pregnant Women, and Women with Benign Ovarian Tumors. Dis Markers 2019;2019:3890906. [PMID: 31583027 DOI: 10.1155/2019/3890906] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
25 Brenk A, Bodzek P, Baliś M, Barbachowska A, Janosz I, Olejek A. Usefulness of HE4 protein in differentiation of pelvic masses in woman. Prz Menopauzalny 2019;18:27-32. [PMID: 31114455 DOI: 10.5114/pm.2019.84154] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Wang L, Sun Y, Cai X, Fu G. The diagnostic value of human epididymis protein 4 as a novel biomarker in patients with renal dysfunction. Int Urol Nephrol 2018;50:2043-8. [PMID: 30006786 DOI: 10.1007/s11255-018-1930-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
27 Zhang M, Yuan L, Yao F, Cao P, Rong J, Zhang B, Su J. Human epididymis protein 4 concentration is not associated with liver fibrosis and cirrhosis in a case control study. Clin Chim Acta 2018;484:213-7. [PMID: 29864404 DOI: 10.1016/j.cca.2018.05.051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Ren Y, Xie J, Lin F, Luo W, Zhang Z, Mao P, Zhong R, Liang Y, Yang Z. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study. Int Immunopharmacol 2018;60:189-93. [PMID: 29747124 DOI: 10.1016/j.intimp.2018.04.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
29 Piek A, Du W, de Boer RA, Silljé HHW. Novel heart failure biomarkers: why do we fail to exploit their potential? Crit Rev Clin Lab Sci 2018;55:246-63. [PMID: 29663841 DOI: 10.1080/10408363.2018.1460576] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
30 Wan J, Wang Y, Cai G, Liang J, Yue C, Wang F, Song J, Wang J, Liu M, Luo J, Li L. Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease. Oncotarget. 2016;7:67748-67759. [PMID: 27589683 DOI: 10.18632/oncotarget.11682] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
31 Fan Q, Luo G, Yi T, Wang Q, Wang D, Zhang G, Jiang X, Guo X. Diagnostic value of urinary-to-serum human epididymis protein 4 ratio in ovarian cancer. Biomed Rep 2017;7:67-72. [PMID: 28685063 DOI: 10.3892/br.2017.913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]